公开(公告)号：US20230321172A1

公开(公告)日：2023-10-12

申请号：US17953859

申请日：2022-09-27

申请人： THE AFFILIATED HOSPITAL OF JIANGXI UNIVERSITY OF TCM

发明人： Qi DAI ,  Kunshan CHEN ,  Xiaoqi ZHOU

IPC分类号： A61K36/489 ,  A61K36/17 ,  A61K36/804 ,  A61K36/54 ,  A61K36/24 ,  A61K36/31 ,  A61K36/8884 ,  A61K36/484 ,  A61K36/90 ,  A61K36/481 ,  A61K36/236 ,  A61K36/288 ,  A61K36/287 ,  A61K36/86 ,  A61K36/286 ,  A61K36/21 ,  A61K36/258

CPC分类号： A61K36/489 ,  A61K36/17 ,  A61K36/21 ,  A61K36/236 ,  A61K36/24 ,  A61K36/258 ,  A61K36/286 ,  A61K36/287 ,  A61K36/288 ,  A61K36/31 ,  A61K36/481 ,  A61K36/484 ,  A61K36/54 ,  A61K36/804 ,  A61K36/86 ,  A61K36/8884 ,  A61K36/90

摘要： A traditional Chinese medicine composition for treating hand-foot syndrome after targeted drug treatment is mainly prepared from the following components by weight: 20-50 parts of Radix Sophorae Flavescentis, 20-50 parts of Herba Taraxaci, 20-50 parts of Flos Chrysanthemi Indici, and 20-50 parts of Herba Cum Radice Violae Yedoensitis, 20-50 parts of Rhizoma Smilacis Glabrae, 30-60 parts of Radix Astragali Seu Hedysari, 10-35 parts of Kochia scoparia (L.) Schrad, 10-45 parts of Carthamus tinctorius L., 15-45 parts of Cortex Radicis Dictamni Dasycarpi, 5-15 parts of Herba Ephedrae, 5-25 parts of Angelica sinensis, 5-25 parts of Rhizoma Ligustici Chuangxiong, 10-30 parts of Radix Rehmanniae, 5-15 parts of Ramulus cinnamomi, 10-30 parts of Cynanchum otophyllum Schneid, 5-15 parts of Semen Sinapis Albae, 5-20 parts of Arisaema heterophyllum Blume, 5-20 parts of Typhonium blumei Nicolson & Sivadasan, and 10-40 parts of Radix Glycyrrhizae.

公开(公告)号：US20230158092A1

公开(公告)日：2023-05-25

申请号：US17990699

申请日：2022-11-20

申请人： Ming Jie WU

发明人： Ming Jie WU

IPC分类号： A61K36/428 ,  A61K36/75 ,  A61K36/758 ,  A61K36/062 ,  A61K36/288 ,  A61K36/539 ,  A61K36/537 ,  A61K36/9066 ,  A61K36/90 ,  A61K36/79 ,  A61K36/233 ,  A61K36/074 ,  A61K36/258 ,  A61K35/586 ,  A23L33/105

CPC分类号： A61K36/428 ,  A61K36/75 ,  A61K36/758 ,  A61K36/062 ,  A61K36/288 ,  A61K36/539 ,  A61K36/537 ,  A61K36/9066 ,  A61K36/90 ,  A61K36/79 ,  A61K36/233 ,  A61K36/074 ,  A61K36/258 ,  A61K35/586 ,  A23L33/105

摘要： The invention provides unique compositions containing mixtures of extracts from medicinal plants and animal parts, as well as related uses for improving health and treating diseases. The inventive compositions provide a wide range of health benefits in the human body in comparison to effects from individual components contained therein.

公开(公告)号：US20160206673A1

公开(公告)日：2016-07-21

申请号：US14598033

申请日：2015-01-15

申请人： David Miller ,  Stephanie Lynn

发明人： David Miller ,  Stephanie Lynn

IPC分类号： A61K36/258 ,  A61K36/537 ,  A61K49/00 ,  A61K36/90 ,  A61K36/73 ,  A61K36/898 ,  A61K36/23 ,  A61K36/888 ,  A61K36/71 ,  A61K36/533 ,  A61K36/288 ,  A61K36/899 ,  A61K36/287 ,  A61K36/53 ,  A61K36/185 ,  A61K36/74 ,  A61K36/82 ,  A61K36/88 ,  A61K9/00

CPC分类号： A61K36/258 ,  A23L33/10 ,  A23L33/105 ,  A23V2002/00 ,  A61K9/0053 ,  A61K9/0095 ,  A61K36/185 ,  A61K36/23 ,  A61K36/287 ,  A61K36/288 ,  A61K36/53 ,  A61K36/533 ,  A61K36/537 ,  A61K36/71 ,  A61K36/73 ,  A61K36/74 ,  A61K36/82 ,  A61K36/88 ,  A61K36/888 ,  A61K36/898 ,  A61K36/899 ,  A61K36/90 ,  A23V2200/30 ,  A23V2250/21 ,  A23V2250/2126 ,  A61K2300/00

摘要： The present application relates to a synergistic blend of ingredients and a method of using the synergistic blend for benefiting health and improving sexual performance.

摘要翻译： 本申请涉及成分的协同混合和使用协同混合物以有益于健康和改善性表现的方法。

公开(公告)号：US10821149B2

公开(公告)日：2020-11-03

申请号：US15175778

申请日：2016-06-07

申请人： INFINITUS (CHINA) COMPANY LTD.

发明人： Bin Shi ,  Xiaolei Guo ,  Chung Wah Ma ,  Chuixin Qin ,  Zhen Luo ,  Wei Zhang

IPC分类号： A61K36/8994 ,  A61K36/896 ,  A61K36/28 ,  A61K36/88 ,  A61K36/884 ,  A61K36/488 ,  A23L33/105 ,  A61K36/68 ,  A61K36/90

摘要： The present invention relates to the pharmaceutical field, particularly to a composition and the use thereof. The composition serves to lower uric acid through the combination of several traditional Chinese medicines of Smilacis glabra rhizoma, Cichorii herba, Plantaginis herba and Coicis semen. On the basis of the combination of the traditional Chinese medicines described above, the addition of Alismatis rhizoma is able to improve the effect of lowering uric acid more significantly. Further, on the basis of the combination of the traditional Chinese medicines described above, the addition of tuna was able to improve the effect of lowering uric acid more significantly. A comprehensive analysis of the experimental results described above indicates that the compositions provided in the present invention have a significant effect of lowering uric acid.

公开(公告)号：US20150265668A1

公开(公告)日：2015-09-24

申请号：US14733771

申请日：2015-06-08

申请人： HAUS BIOCEUTICALS, INC.

发明人： Tomy YESUDAS ,  Philip ALEX ,  Michael CENTOLA ,  Adam Joshua PAYNE

IPC分类号： A61K36/90 ,  A61K36/185 ,  A61K36/22 ,  A61K36/899 ,  A61K36/71 ,  A61K36/31 ,  A61K36/76 ,  A61K36/66 ,  A61K36/29 ,  A61K36/808 ,  A61K36/48 ,  A61K36/28 ,  A61K36/77 ,  A61K36/24 ,  A61K36/68 ,  A61K36/23

CPC分类号： A61K36/90 ,  A61K36/185 ,  A61K36/22 ,  A61K36/23 ,  A61K36/24 ,  A61K36/27 ,  A61K36/28 ,  A61K36/29 ,  A61K36/31 ,  A61K36/35 ,  A61K36/48 ,  A61K36/66 ,  A61K36/68 ,  A61K36/71 ,  A61K36/76 ,  A61K36/77 ,  A61K36/808 ,  A61K36/899 ,  A61K2300/00

摘要： Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.

摘要翻译： 本文公开了用于缓解皮肤病症状的草药制剂。 制剂还可以与活性或非活性药物成分和/或药学上可接受的赋形剂组合。

公开(公告)号：US20130149398A1

公开(公告)日：2013-06-13

申请号：US13471913

申请日：2012-05-15

申请人： Tomy YESUDAS ,  Philip ALEX ,  Michael CENTOLA ,  Adam Joshua PAYNE

发明人： Tomy YESUDAS ,  Philip ALEX ,  Michael CENTOLA ,  Adam Joshua PAYNE

IPC分类号： A61K36/90 ,  A61K36/185 ,  A61K36/22 ,  A61K36/71 ,  A61K36/899 ,  A61K36/31 ,  A61K36/76 ,  A61K36/66 ,  A61K36/29 ,  A61K36/48 ,  A61K36/28 ,  A61K36/27 ,  A61K36/68 ,  A61K36/77 ,  A61K36/23

CPC分类号： A61K36/90 ,  A61K36/185 ,  A61K36/22 ,  A61K36/23 ,  A61K36/24 ,  A61K36/27 ,  A61K36/28 ,  A61K36/29 ,  A61K36/31 ,  A61K36/35 ,  A61K36/48 ,  A61K36/66 ,  A61K36/68 ,  A61K36/71 ,  A61K36/76 ,  A61K36/77 ,  A61K36/808 ,  A61K36/899 ,  A61K2300/00

摘要： Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.

公开(公告)号：US20110033556A1

公开(公告)日：2011-02-10

申请号：US12793958

申请日：2010-06-04

申请人： Zheming Jin ,  Xitian Zhang

发明人： Zheming Jin ,  Xitian Zhang

IPC分类号： A61K36/481 ,  A61K36/282 ,  A61K36/18 ,  A61K36/28 ,  A61K35/56 ,  A61K36/258 ,  A61K36/482 ,  A61K36/484 ,  A61K36/605 ,  A61K36/8969 ,  A61K36/815 ,  A61K36/074 ,  A61K36/65 ,  A61K36/537 ,  A61K36/894 ,  A61K36/748 ,  A61K36/804 ,  A61K35/64 ,  A61K36/906 ,  A61K36/884 ,  A61K36/23 ,  A61K36/704 ,  A61K36/90 ,  A61K36/355 ,  A61K36/81 ,  A61K36/428 ,  A61K36/536 ,  A61K36/539 ,  A61K35/38 ,  A61K36/16 ,  A61K36/535 ,  A61K36/71 ,  A61K36/63 ,  A61P31/14 ,  A61P31/20 ,  A61P31/06 ,  A61P31/18 ,  A61P29/00 ,  A61P1/16

CPC分类号： A61K36/00

摘要： A natural pharmaceutical preparation for treating hypoproteinemia, includes at least one member selected from the group consisting of a drug of increasing human serum albium, a drug of improving and enhance immunity, a drug of treating hepatitis B, a drug of treating Hepatitis C, a drug of treating acquired immune deficiency syndrome (AIDS), a drug of treating Tuberculosis, a drug of treat Fibrosis, a drug of treating hydrothorax, a drug of easing pain, a drug of stopping diarrhea, a drug of arresting coughing, a drug of reducing inflammation, and a drug of increasing urine.

摘要翻译： 一种用于治疗低蛋白血症的天然药物制剂，包括至少一种选自增加人血清白蛋白的药物，改善和增强免疫力的药物，治疗乙型肝炎的药物，治疗丙型肝炎的药物，a 治疗获得性免疫缺陷综合征（AIDS）的药物，治疗结核病的药物，治疗性纤维化药物，治疗胸水的药物，缓解疼痛的药物，停止腹泻的药物，止咳药的药物 减少炎症，增加尿液的药物。

公开(公告)号：US12076362B2

公开(公告)日：2024-09-03

申请号：US17659507

申请日：2022-04-18

申请人： Mildred Brenda Briggs

发明人： Mildred Brenda Briggs

IPC分类号： A61K31/05 ,  A61K36/324 ,  A61K36/328 ,  A61K36/534 ,  A61K36/63 ,  A61K36/90 ,  A61K36/9066 ,  A61K47/44

CPC分类号： A61K36/9066 ,  A61K31/05 ,  A61K36/324 ,  A61K36/328 ,  A61K36/534 ,  A61K36/63 ,  A61K47/44

摘要： A botanical pain relief ointment contains a botanical fat base, turmeric oil, myrrh oil, frankincense oil, peppermint oil, an anti-inflammatory botanical oil, and CBD isolate oil. A method of producing the botanical pain relief ointment includes sequentially mixing shea butter, turmeric oil, myrrh oil, frankincense oil, peppermint oil, olive oil, and CBD isolate oil in a blender on low speed until creamy and smooth. The ointment is all natural and is believed to have no side effects.

公开(公告)号：US20220288126A1

公开(公告)日：2022-09-15

申请号：US17828573

申请日：2022-05-31

申请人： Jeffrey M. Golini

发明人： Jeffrey M. Golini

IPC分类号： A61K35/20 ,  A23L5/00 ,  A23L33/125 ,  A61K31/198 ,  A61K31/337 ,  A61K36/185 ,  A61K36/90 ,  A61K45/06 ,  A23L29/30 ,  A23L33/105 ,  A23L33/115 ,  A23L33/15 ,  A23L33/175 ,  A23L33/00 ,  A23L33/16 ,  A23L33/185 ,  A23L33/19 ,  A61K36/889 ,  A61K31/718 ,  A61K33/00 ,  A61K33/42 ,  A61K31/661 ,  A61K36/899 ,  A61K38/16

摘要： The invention relates to a pharmaceutical or nutraceutical composition comprising an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof. Such compositions are useful for treating a range of diseases and conditions. They also give rise to beneficial physiological effects such as, for example, increasing physical strength, muscle mass and endurance.

公开(公告)号：US20200368308A1

公开(公告)日：2020-11-26

申请号：US16842528

申请日：2020-04-07

申请人： HAUS BIOCEUTICALS, INC.

发明人： Tomy YESUDAS ,  Philip ALEX ,  Michael CENTOLA ,  Adam Joshua PAYNE

IPC分类号： A61K36/90 ,  A61K36/23 ,  A61K36/185 ,  A61K36/22 ,  A61K36/71 ,  A61K36/899 ,  A61K36/31 ,  A61K36/76 ,  A61K36/66 ,  A61K36/29 ,  A61K36/48 ,  A61K36/28 ,  A61K36/27 ,  A61K36/68 ,  A61K36/77 ,  A61K36/808 ,  A61K36/35 ,  A61K36/24

摘要： Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.